LCD L38394: MolDX: Pharmacogenomics Testing — CGS
Policy LCD-L38394 · Clinical Laboratory
New pharmacogenomics testing affects billing from 2025.
Code intelligence
Z13.79 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code Z13.79.
Normal code riskView ICD-10 detail
Signal breakdown
4 shown · 4 total in platform
Risk: Normal
0
Critical
0%
0
High
0%
4
Routine
100%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Routine
LCD L38335: MolDX: Pharmacogenomics Testing — Noridian
Policy LCD-L38335 · Clinical Laboratory
Prepare for changes in pharmacogenomics testing billing.
LCD L38294: MolDX: Pharmacogenomics Testing — Palmetto GBA
Policy LCD-L38294 · Clinical Laboratory
New LCD for Pharmacogenomics Testing effective 10/02/2025
LCD L38435: MolDX: Pharmacogenomics Testing — WPS
Policy LCD-L38435 · Clinical Laboratory
New billing guidelines for Pharmacogenomics Testing effective 2025.
Audit documentation
Building an audit file that includes Z13.79?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription